MedPath

STADA PHARMACEUTICALS (ASIA) LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

43

PPB:43

Drug Approvals

DASATINIB STADA TABLETS 50MG

Approval Date
Dec 23, 2024
PPB

DASATINIB STADA TABLETS 20MG

Approval Date
Dec 23, 2024
PPB

DASATINIB STADA TABLETS 70MG

Approval Date
Dec 23, 2024
PPB

ERLOTINIB STADA TABLETS 25MG

Approval Date
Dec 13, 2024
PPB

ERLOTINIB STADA TABLETS 150MG

Approval Date
Dec 13, 2024
PPB

ERLOTINIB STADA TABLETS 100MG

Approval Date
Dec 13, 2024
PPB

APREPITANT STADA CAPSULES 125MG AND 80MG

Approval Date
Nov 22, 2024
PPB

ABIRATERON STADA TABLETS 250MG

Approval Date
Dec 15, 2023
PPB

GEFITINIB STADA TABLETS 250MG

Approval Date
Nov 28, 2023
PPB

AZACITIDINE STADA POWDER FOR SUSPENSION FOR INJECTION 100MG

Approval Date
Jun 14, 2023
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.